Keating Financial Advisory Services’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$467K Buy
1,289
+84
+7% +$28.8K 0.06% 201
2026
Q1
$424K Buy
1,205
+77
+7% +$27.4K 0.07% 198
2025
Q4
$369K Buy
+1,128
New +$358K 0.05% 261

Other funds holding AMGN

Keating Financial Advisory Services's AMGN Position: Q2 2026 in Review

Keating Financial Advisory Services increased its Amgen (AMGN) stake by 7% in Q2 2026, buying an estimated $28.8K and bringing the position to 1,289 shares worth $467K. The position accounts for 0.06% of the portfolio, ranked #201.

Keating Financial Advisory Services first reported a position in AMGN in Q4 2025 and has held it in 3 quarters since. 3,164 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Keating Financial Advisory Services held 1,289 shares of Amgen worth $467K as of Q2 2026.
  • Keating Financial Advisory Services bought 84 Amgen shares in Q2 2026, an estimated $28.8K.
  • Amgen made up 0.06% of Keating Financial Advisory Services's portfolio in Q2 2026, its #201 holding.
  • Keating Financial Advisory Services first reported a position in Amgen in Q4 2025 and has held it in 3 quarters since.
  • 3,164 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Keating Financial Advisory Services's 13F filing for Q2 2026, filed 11 Aug 2026.